Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1 beta treatment: a novel role for CCL20 in chronic mucus hypersecretion
EUROPEAN RESPIRATORY JOURNAL
Authors: Faiz, Alen; Weckmann, Markus; Tasena, Haitatip; Vermeulen, Corneel J.; Van den Berge, Maarten; ten Hacken, Nick H. T.; Halayko, Andrew J.; Ward, Jeremy P. T.; Lee, Tak H.; Tjin, Gavin; Black, Judith L.; Haghi, Mehra; Xu, Cheng-Jian; King, Gregory G.; Farah, Claude S.; Oliver, Brian G.; Heijink, Irene H.; Burgess, Janette K.
Abstract
Chronic mucus hypersecretion (CMH) contributes to the morbidity and mortality of asthma, and remains uncontrolled by current therapies in the subset of patients with severe, steroidresistant disease. Altered cross-talk between airway epithelium and airway smooth muscle cells (ASMCs), driven by pro-inflammatory cytokines such as interleukin (IL)-1 beta, provides a potential mechanism that influences CMH. This study investigated mechanisms underlying CMH by comparing IL-1 beta-induced gene expression profiles between asthma and control-derived ASMCs and the subsequent paracrine influence on airway epithelial mucus production in vitro. IL-1 beta-treated ASMCs from asthmatic patients and healthy donors were profiled using microarray analysis and ELISA. Air liquid interface (AM-cultured CALU-3 and primary airway epithelial cells were treated with identified candidates and mucus production assessed. The IL-1 beta-induced CCL20 expression and protein release was increased in ASMCs from moderate compared with mild asthmatic patients and healthy controls. 1L-10 induced lower MIR146A expression in asthma-derived ASMCs compared with controls. Decreased MIR146A expression was validated in vivo in bronchial biopsies from 16 asthmatic patients versus 39 healthy donors. miR-146a-5p overexpression abrogated CCL20 release in ASMCs. CCL20 treatment of ALI-cultured CALU-3 and primary airway epithelial cells induced mucus production, while CCL20 levels in sputum were associated with increased levels of CMH in asthmatic patients. Elevated CCL20 production by ASMCs, possibly resulting from dysregulated expression of the antiinflammatory miR-146a-5p, may contribute to enhanced mucus production in asthma.
In Vitro Epithelial Organoid Generation Induced by Substrate Nanotopography
SCIENTIFIC REPORTS
Authors: Shen, Yusheng; Hou, Youmin; Yao, Shuhuai; Huang, Pingbo; Yobas, Levent
Abstract
The extracellular matrix ECM) exhibits tissue-specific topography and composition and plays a crucial role in initiating the biochemical and biomechanical signaling required for organizing cells into distinct tissues during development. How single cells assemble into structures featuring specific shapes in response to external cues is poorly understood. We examined the effect of substrate nanotopography on the morphogenesis of several types of epithelial cells and found that in response to the topography, Calu-3 and MDCK-II cells formed organoids that closely resemble their morphologyin vivo. This finding represents the first demonstration that substrate nanotopography, one of the first physical cues detected by cells, can by itself induce epithelial tissue-like organization. Our results provide insights, in terms of a new aspect of ECM topography, into the design of future tissue-engineering systems and the study of mechanosignaling in the epithelium during normal development and tumor progression.